Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00393913 · ClinicalTrials.gov registry record
Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 144
- Enrollment target
NCT00393913 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 144 participants.
The verdict
NCT00393913 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
Obstructive sleep apnea (OSA) is a serious sleep disorder in which a person repeatedly stops breathing, or experiences shallow breathing for short periods of time during sleep. Daytime sleepiness is a common symptom of OSA and may affect an individual's level of alertness throughout the day. The primary purpose of this study is to evaluate the relationship between the severity of sleep-disordered breathing and levels of daytime alertness at baseline (untreated state) in a group of subjects with and without sleep apnea. In addition the change in daytime sleepiness in subjects with sleep apnea being treated with a continuous positive airway pressure (CPAP) machine, a common treatment for OSA will also be assessed.
Interventions
- DEVICE Continuous Positive Airway Pressure (CPAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2006-10 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00393913
The ClinicalTrials.gov registry entry for NCT00393913 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Positive Airway Pressure (CPAP) is the first listed.
NCT00393913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00393913 about?
NCT00393913 is a clinical study titled "Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness". Obstructive sleep apnea (OSA) is a serious sleep disorder in which a person repeatedly stops breathing, or experiences shallow breathing for short periods of time during sleep. Daytime sleepiness is a common symptom of OSA and may affect an individual's level of alertness throughout the day. The pri...
What is the current status of trial NCT00393913?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2006-10. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00393913?
The interventions under investigation include: Continuous Positive Airway Pressure (CPAP) (DEVICE).
Who is sponsoring clinical trial NCT00393913?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.